Results 91 to 100 of about 3,120 (153)

Assessing the benefit of incorporating an anti-CD38 monoclonal antibody into second- or third-line systemic treatment for patients with relapsed/refractory multiple myeloma: results from the French real-world EMMY study. [PDF]

open access: yesHaematologica
Chalopin T   +22 more
europepmc   +1 more source

Efficacy and safety of dapsone in adult primary immune thrombocytopenia. [PDF]

open access: yesBlood Adv
Larue M   +22 more
europepmc   +1 more source

Stage I placental site trophoblastic tumor with complete response after pembrolizumab. [PDF]

open access: yesGynecol Oncol Rep
Descargues P   +11 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy